Healthcare utilization, provisioning of post-exposure prophylaxis, and estimation of human rabies burden in Madagascar

Among individuals who received PEP during the study period, 87,518 (82.4%) were exposed in mainland France (free of rabies in non-flying terrestrial mam- mals but enzootic for

1 National Laboratory for Rabies, Virology Unit, Route de l ’ Institut Pasteur, Institut Pasteur de Madagascar, BP 1274, 101 Antananarivo, Madagascar Full list of author information

We investigated the following scenarios (assumptions detailed in the panel): (1) status quo, with countries delivering post-exposure prophylaxis according to current provision

Unless new worldwide shortages lead to situations where no fatalities among vaccine noncompleters are documented, and unless revolutionary new techniques or biomarkers such as in

Salahuddin et al., Rabies post-exposure prophylaxis: A systematic review on abridged vaccination schedules and the effect of changing administration routes during a single

For different PEP regimens, clinic throughputs and consumables for vaccine administration, we evaluated the cost per patient treated, costs to patients and potential to treat

Rabies diagnosis was confirmed by direct fluorescent antibody test (DFAT) using postmortem brain samples (Figure 1).. The patient did not receive the four doses of rabies

Although a majority of the students had a good level of general knowledge on rabies, some important gaps were identified (Table 2 ). The students usually did not know the fatal